Evidence map›Paper›PMID 33414495›Full record

ArticleScientific reports2021

Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study.

Hana Štorkánová, Sabína Oreská, Maja Špiritović, Barbora Heřmánková, Kristýna Bubová, Martin Komarc, Karel Pavelka, Jiří Vencovský, Jörg H W Distler, Ladislav Šenolt and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 3 pooled it
685.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 3 syntheses or guidelines pooled it, 5,045 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Microbe-plant-nanoparticle interactions: role in bioremediation of petroleum hydrocarbons.Water science and technology : a journal of the International Association on Water Pollution Research · 2024
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Hana ŠtorkánováInstitute of Rheumatology, Prague, Czech Republic.
Sabína OreskáInstitute of Rheumatology, Prague, Czech Republic.
Maja ŠpiritovićInstitute of Rheumatology, Prague, Czech Republic.
Barbora HeřmánkováDepartment of Physiotherapy, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic.
Kristýna BubováInstitute of Rheumatology, Prague, Czech Republic.
Martin KomarcDepartment of Methodology, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic.
Karel PavelkaInstitute of Rheumatology, Prague, Czech Republic.
Jiří VencovskýInstitute of Rheumatology, Prague, Czech Republic.
Jörg H W DistlerDepartment of Internal Medicine III and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany.
Ladislav ŠenoltInstitute of Rheumatology, Prague, Czech Republic.
Radim BečvářInstitute of Rheumatology, Prague, Czech Republic.
Michal TomčíkInstitute of Rheumatology, Prague, Czech Republic. tomcik@revma.cz.
Charles University · CZInstitute of Rheumatology · CZFriedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our previous study demonstrated increased expression of Heat shock protein (Hsp) 90 in the skin of patients with systemic sclerosis (SSc). We aimed to evaluate plasma Hsp90 in SSc and characterize its association with SSc-related features. Ninety-two SSc patients and 92 age-/sex-matched healthy controls were recruited for the cross-sectional analysis. The longitudinal analysis comprised 30 patients with SSc associated interstitial lung disease (ILD) routinely treated with cyclophosphamide. Hsp90 was increased in SSc compared to healthy controls. Hsp90 correlated positively with C-reactive protein and negatively with pulmonary function tests: forced vital capacity and diffusing capacity for carbon monoxide (DLCO). In patients with diffuse cutaneous (dc) SSc, Hsp90 positively correlated with the modified Rodnan skin score. In SSc-ILD patients treated with cyclophosphamide, no differences in Hsp90 were found between baseline and after 1, 6, or 12 months of therapy. However, baseline Hsp90 predicts the 12-month change in DLCO. This study shows that Hsp90 plasma levels are increased in SSc patients compared to age-/sex-matched healthy controls. Elevated Hsp90 in SSc is associated with increased inflammatory activity, worse lung functions, and in dcSSc, with the extent of skin involvement. Baseline plasma Hsp90 predicts the 12-month change in DLCO in SSc-ILD patients treated with cyclophosphamide.

Indexed as

AdultAgedCarbon MonoxideCase-Control StudiesC-Reactive ProteinCross-Sectional StudiesCyclophosphamideDermatitisFemaleHSP90 Heat-Shock ProteinsHumansImmunosuppressive AgentsLongitudinal StudiesLungLung Diseases, InterstitialMaleCarbon MonoxideC-Reactive ProteinCyclophosphamideHSP90 Heat-Shock ProteinsImmunosuppressive Agents

Identifiers

PMID33414495
PMCPMC7791137
OpenAlexW3118577024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.